Leaders at EBRAINS, a collection of tools and data resources for basic neuroscience research, are finalizing the platform’s ...

Cumulus Neuroscience (Cumulus; the Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today announced the publication ...

The 1990s were declared the "Decade of the Brain"—yet, 25 years later, much about the brain remains a mystery. Our brain is the most protected and least accessible organ in the human body, making real ...

Neuroscience is a vast field of study containing a range of narrower subfields. Each involves a spotlight on the brain and other parts of the nervous system, connecting them to one or more zones of ...

Phase 1/2 FUNCTION ALS trial initiated in Europe with additional global regions anticipated in 2026 First patients dosed in LAUNCH ALS, an investigator-initiated trial in China conducted in partnershi ...

JUPITER, FL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company focused on neuroinflammation and central ...

Axon Neuroscience’s active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer’s disease phase 2 clinical trial (supported by a USD ...

Brenna Swanston is an education-focused editor and writer with a particular interest in education equity and alternative educational paths. As a newswriter in her early career, Brenna's education ...

Pharmaceutical executive and physician with strong experience in global research and developmentOver 20 years’ experience in all stages of clinical development across multiple indications, including ...